Mga Batayang Estadistika
| CIK | 1832352 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to CA Healthcare Acquisition Corp - Class A
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 14, 2022 |
CAHC / CA Healthcare Acquisition Corp / INTEGRATED CORE STRATEGIES (US) LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1) CA HEALTHCARE ACQUISITION CORP. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 12510W107 (CUSIP Number) DECEMBER 31, 2021 (Date of event which requires filing of this statement) Check the appropriate box |
|
| October 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-39947 CA Healthcare Acquisition Corp. (Exact name of registrant as speci |
|
| October 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 28, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) |
|
| October 4, 2021 |
AMENDED AND RESTATED WARRANT AGREEMENT Exhibit 4.1 Execution Version AMENDED AND RESTATED WARRANT AGREEMENT THIS AMENDED AND RESTATED WARRANT AGREEMENT (this ?Agreement?), dated as of September 28, 2021, is entered into by and among (i) LumiraDx Limited, a Cayman Island exempted company limited by shares with company number 314391 (the ?Company?); (ii) Continental Stock Transfer & Trust Company, a New York Limited Purpose Trust Company |
|
| October 4, 2021 |
EX-4.2 3 tm2128570d4ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 NON-REDEMPTION AGREEMENT THIS NON-REDEMPTION AGREEMENT (this “Agreement”), dated as of September [], 2021, is made by and between CA Healthcare Sponsor LLC, a Delaware limited liability company (the “Sponsor”) and the undersigned investor (“Investor”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to |
|
| September 29, 2021 |
Exhibit 99.1 LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp. ? LumiraDx?s common shares will commence trading on September 29, 2021 on Nasdaq under the ticker symbol ?LMDX? ? The Merger values LumiraDx at $3.0 billion (excluding the amounts raised by CAHC in its initial public offering) BOSTON, MA and LONDON, UK, Sept. 28, 2021 ? Lumir |
|
| September 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 28, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) |
|
| September 24, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) |
|
| September 24, 2021 |
SC 13G 1 p21-2215sc13g.htm SENVEST MANAGEMENT, LLC SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CA Healthcare Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 12510W107 (CUSIP Number) September 17, 2021 (Date of Event Which Requires Filing of this |
|
| September 24, 2021 |
DEFA14A 1 tm2128067d3defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State |
|
| September 24, 2021 |
EX-2.2 3 tm2128067d1ex2-2.htm EXHIBIT 2.2 Exhibit 2.2 Execution Version ACKNOWLEDGMENT AND WAIVER This Acknowledgment and Waiver (the “Waiver”) is made as of September 23, 2021 by and among CA Healthcare Acquisition Corp., a Delaware corporation (“CAH”), CA Healthcare Sponsor LLC, a Delaware limited liability company (the “Sponsor”), LumiraDx Limited, a Cayman Islands exempted company limited by s |
|
| September 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) |
|
| September 24, 2021 |
EX-2.1 2 tm2128067d1ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 NON-REDEMPTION AGREEMENT THIS NON-REDEMPTION AGREEMENT (this “Agreement”), dated as of September 23, 2021, is made by and between CA Healthcare Sponsor LLC, a Delaware limited liability company (the “Sponsor”) and the undersigned investor (“Investor”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to |
|
| September 10, 2021 |
DEFA14A 1 d202585ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ |
|
| September 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 7, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) ( |
|
| September 8, 2021 |
EX-99.2 3 tm2127092d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination CA Healthcare’s Board Recommends Stockholders Vote “FOR” the Business Combination and “FOR” all of the related proposals All stockholders of CA Healthcare as of Septembe |
|
| September 8, 2021 |
Transforming Community - Based Healthcare Corporate Presentation September 2021 Exhibit 99.1 Transforming Community - Based Healthcare Corporate Presentation September 2021 This presentation (together with oral statements made in connection herewith, this ?Presentation?) is provided for informatio nal purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential b us iness combination between LumiraDx Limited (?Lum |
|
| September 8, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 7, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) ( |
|
| September 8, 2021 |
Transforming Community - Based Healthcare Corporate Presentation September 2021 EX-99.1 2 tm2127092d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Transforming Community - Based Healthcare Corporate Presentation September 2021 This presentation (together with oral statements made in connection herewith, this “Presentation”) is provided for informatio nal purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential b us ine |
|
| September 8, 2021 |
Exhibit 99.2 CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination CA Healthcare?s Board Recommends Stockholders Vote ?FOR? the Business Combination and ?FOR? all of the related proposals All stockholders of CA Healthcare as of September 1st, 2021 are encouraged to vote their shar |
|
| September 3, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy S |
|
| August 30, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 27, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) (Co |
|
| August 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 27, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) (Co |
|
| August 30, 2021 |
SECOND AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER EX-2.1 2 tm2126506d1ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 SECOND AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER SECOND AMENDMENT, dated as of August 27, 2021 (this “Amendment”), to the Agreement and Plan of Merger, dated as of April 6, 2021 (the “Agreement”), by and among (i) LumiraDx Limited, a Cayman Islands exempted company limited by shares with company number 314391 (the “Company”), (ii) LumiraDx |
|
| August 20, 2021 |
AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER EX-2.1 2 tm2125188d1ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER AMENDMENT, dated as of August 19, 2021 (this “Amendment”), to the Agreement and Plan of Merger, dated as of April 6, 2021 (the “Agreement”), by and among (i) LumiraDx Limited, a Cayman Islands exempted company limited by shares with company number 314391 (the “Company”), (ii) LumiraDx Merger Sub, In |
|
| August 20, 2021 |
AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER Exhibit 2.1 AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER AMENDMENT, dated as of August 19, 2021 (this ?Amendment?), to the Agreement and Plan of Merger, dated as of April 6, 2021 (the ?Agreement?), by and among (i) LumiraDx Limited, a Cayman Islands exempted company limited by shares with company number 314391 (the ?Company?), (ii) LumiraDx Merger Sub, Inc., a Delaware corporation and a wholly-ow |
|
| August 20, 2021 |
Exhibit 99.1 LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics ? Revised transaction terms adjust LumiraDx?s pro forma valuation for the combined group from $5 billion to $3 billion (excluding $115 million raised by CA Healthcare Acquisition Corp (?CAHC?) in its initial public offering). ? Terms establish |
|
| August 20, 2021 |
425 1 d162386d425.htm 425 Filed by LumiraDx Limited Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CA Healthcare Acquisition Corp. Commission File No. 001-39947 Date: August 20, 2021 LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Gene |
|
| August 20, 2021 |
425 1 tm2125188d18k.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisd |
|
| August 20, 2021 |
Exhibit 99.1 LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics ? Revised transaction terms adjust LumiraDx?s pro forma valuation for the combined group from $5 billion to $3 billion (excluding $115 million raised by CA Healthcare Acquisition Corp (?CAHC?) in its initial public offering). ? Terms establish |
|
| August 20, 2021 |
CA HEALTHCARE ACQUISITION CORP. Amendment TO the AMENDED AND RESTATED SPONSOR AGREEMENT Exhibit 4.1 CA HEALTHCARE ACQUISITION CORP. Amendment TO the AMENDED AND RESTATED SPONSOR AGREEMENT This AMENDMENT TO The AMENDED AND RESTATED SPONSOR Agreement (this ?Amendment?) is made as of August 19, 2021, by and among CA Healthcare Acquisition Corp., a Delaware corporation (?CAH?), CA Healthcare Sponsor LLC (the ?Sponsor?) and each of the undersigned individuals, each of whom is a member of |
|
| August 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) (Co |
|
| August 20, 2021 |
CA HEALTHCARE ACQUISITION CORP. Amendment TO the AMENDED AND RESTATED SPONSOR AGREEMENT EX-4.1 3 tm2125188d1ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 CA HEALTHCARE ACQUISITION CORP. Amendment TO the AMENDED AND RESTATED SPONSOR AGREEMENT This AMENDMENT TO The AMENDED AND RESTATED SPONSOR Agreement (this “Amendment”) is made as of August 19, 2021, by and among CA Healthcare Acquisition Corp., a Delaware corporation (“CAH”), CA Healthcare Sponsor LLC (the “Sponsor”) and each of the undersigned |
|
| August 2, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 19, 2021 |
Transforming Community-Based Healthcare Analyst Day July 16, 2021 Confidential and Proprietary Copyright © 2021 LumiraDx Ltd. |
|
| July 16, 2021 |
Exhibit 99.1 Transforming Community - Based Healthcare Analyst Day July 16, 2021 Confidential and Proprietary Copyright ? 2021 LumiraDx Ltd. All Rights Reserved, Worldwide. For discussion purposes only. 2 This presentation (together with oral statements made in connection herewith, this ?Presentation?) is provided for informatio nal purposes only and has been prepared to assist interested parties |
|
| July 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 16, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) (Comm |
|
| July 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 16, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) (Comm |
|
| May 26, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 25, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 18, 2021 |
NT 10-Q 1 tm2114803d2nt10q.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-39947 (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2021 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Repo |
|
| April 14, 2021 |
SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CA HEALTHCARE ACQUISITION CORP. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 12510W107 (CUSIP Number) APRIL 12, 2021 (Date of event which requires filing of this statement) Check the appropriate box to desig |
|
| April 8, 2021 |
425 1 tm2112463d1425.htm 425 Filed by CA Healthcare Acquisition Corp pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: CA Healthcare Acquisition Corp. Commission File No. 001-39947 On April 7, 2021, Ron Zwanziger, Chairman and CEO and Co-founder of LumiraDx Limited (“Lum |
|
| April 7, 2021 |
Covid-Test Startup LumiraDx to Go Public in $5 Billion SPAC Deal EX-99.4 7 tm2112303d1ex99-4.htm EXHIBIT 99.4 Exhibit 99.4 Covid-Test Startup LumiraDx to Go Public in $5 Billion SPAC Deal By Crystal Tse and Bailey Lipschultz April 6, 2021, 9:05 PM CDT · Firm secures $300 million loan, $100 million credit facility · Brick-size LumiraDx device can run 30 different tests LumiraDx Ltd., a diagnostic company that produces Covid-19 tests, is going public through a re |
|
| April 7, 2021 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG LUMIRADX LIMITED, LUMIRADX MERGER SUB, INC. AND CA Healthcare Acquisition Corp., DATED AS OF APRIL 6, 2021 Article 1. DEFINITIONS 4 Section 1.1 Certain Definitions 4 Section 1.2 Further Definitions 16 Section 1.3 Construction. 18 Article 2. TRANSACTIONS 19 Section 2.1 Pre-Closing Transactions. 19 Section 2.2 The Merger. 20 Section 2.3 Closing 2 |
|
| April 7, 2021 |
EX-99.1 4 tm2112303d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp · LumiraDx’s innovative diagnostic testing Platform has been in development since 2014 and is designed to offer a broad menu of tests with lab-comparable performance at a low cost and with results in less th |
|
| April 7, 2021 |
EX-4.1 3 tm2112303d1ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 CA Healthcare Acquisition Corp. 99 Summer Street Suite 200 Boston, MA 02110 April 6, 2021 Re: Amended and Restated Sponsor Agreement Ladies and Gentlemen: This letter (this “Sponsor Agreement”) is being delivered to you in connection with that certain Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and amo |
|
| April 7, 2021 |
Exhibit 99.1 LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp ? LumiraDx?s innovative diagnostic testing Platform has been in development since 2014 and is designed to offer a broad menu of tests with lab-comparable performance at a low cost and with results in less than 12 minutes at the point of care ? This tra |
|
| April 7, 2021 |
EX-2.1 2 tm2112303d1ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG LUMIRADX LIMITED, LUMIRADX MERGER SUB, INC. AND CA Healthcare Acquisition Corp., DATED AS OF APRIL 6, 2021 Article 1. DEFINITIONS 4 Section 1.1 Certain Definitions 4 Section 1.2 Further Definitions 16 Section 1.3 Construction. 18 Article 2. TRANSACTIONS 19 Section 2.1 Pre-Closing Transactions. 19 Sectio |
|
| April 7, 2021 |
Filed by CA Healthcare Acquisition Corp EX-99.3 6 tm2112303d1ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 Filed by CA Healthcare Acquisition Corp pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: CA Healthcare Acquisition Corp. Commission File No. 001-39947 On April 7, 2021, Larry Neiterman, Chairman and CEO of CA Hea |
|
| April 7, 2021 |
425 1 tm2112303d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 6, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jur |
|
| April 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 6, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) (Comm |
|
| April 7, 2021 |
Exhibit 4.1 CA Healthcare Acquisition Corp. 99 Summer Street Suite 200 Boston, MA 02110 April 6, 2021 Re: Amended and Restated Sponsor Agreement Ladies and Gentlemen: This letter (this ?Sponsor Agreement?) is being delivered to you in connection with that certain Agreement and Plan of Merger, dated as of the date hereof (the ?Merger Agreement?), by and among LumiraDx Limited, a Cayman Islands exem |
|
| April 7, 2021 |
Transforming Community - Based Healthcare Corporate Presentation April 2021 EX-99.2 5 tm2112303d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Transforming Community - Based Healthcare Corporate Presentation April 2021 Safe Harbor and Disclaimer This presentation (together with oral statements made in connection herewith, this “Presentation”) is provided for informatio nal purposes only and has been prepared to assist interested parties in making their own evaluation with respect |
|
| April 7, 2021 |
Covid-Test Startup LumiraDx to Go Public in $5 Billion SPAC Deal Exhibit 99.4 Covid-Test Startup LumiraDx to Go Public in $5 Billion SPAC Deal By Crystal Tse and Bailey Lipschultz April 6, 2021, 9:05 PM CDT ? Firm secures $300 million loan, $100 million credit facility ? Brick-size LumiraDx device can run 30 different tests LumiraDx Ltd., a diagnostic company that produces Covid-19 tests, is going public through a reverse merger with a blank-check company. The |
|
| April 7, 2021 |
Filed by CA Healthcare Acquisition Corp Exhibit 99.3 Filed by CA Healthcare Acquisition Corp pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: CA Healthcare Acquisition Corp. Commission File No. 001-39947 On April 7, 2021, Larry Neiterman, Chairman and CEO of CA Healthcare Acquisition Corp. (?CAHC?), and Ron Z |
|
| April 7, 2021 |
Transforming Community - Based Healthcare Corporate Presentation April 2021 Exhibit 99.2 Transforming Community - Based Healthcare Corporate Presentation April 2021 Safe Harbor and Disclaimer This presentation (together with oral statements made in connection herewith, this ?Presentation?) is provided for informatio nal purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential b us iness combination between |
|
| March 5, 2021 |
EX-99.1 2 tm218798d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CA Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 9, 2021 Boston, MA, March 5, 2021– CA Healthcare Acquisition Corp. (NASDAQ: CAHCU) (the “Company”) announced that, commencing March 9, 2020, holders of the units sold in the Company’s initial public offering may elect to |
|
| March 5, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 5, 2021 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction of incorporation) (Comm |
|
| February 4, 2021 |
CA HEALTHCARE ACQUISITION CORP. EX-99.1 2 tm215360d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CA HEALTHCARE ACQUISITION CORP. Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of January 29, 2021 F-3 Notes to Financial Statement F-4 Report of Independent Registered Public Accounting Firm To the Stockholders and the Board of Directors of CA Healthcare Acquisition Corp. Opinion on the Financial Statement We h |
|
| February 4, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 4, 2021 (January 29, 2021) CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction o |
|
| February 1, 2021 |
EX-10.2 6 tm214851d1ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of January 26, 2021, by and between CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s re |
|
| February 1, 2021 |
Exhibit 99.1 January 202 1 2 C O N F I D E N T I A L Is s u e r: CA Healthcare A c q u i s i t i on C orp. O f fer i n g Price : $ 1 0.0 0 /u ni t Offer i ng A mou n t: $ 115 ,0 0 0,000 N umb e r of U ni t s: 11 , 5 0 0,000 U n i ts U nit C omp o si t io n : 1 .0 sh a re of Class A common stock ; 0.5 redeemable w ar r a n t to p u rch a se o n e share of Class A common stock P r i v ate P la c eme |
|
| February 1, 2021 |
Amended and Restated Certificate of Incorporation. EX-3.1 3 tm214851d1ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CA HEALTHCARE ACQUISITION CORP. January 26, 2021 CA Healthcare Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “CA Healthcare Acquisition Corp.”. The certifica |
|
| February 1, 2021 |
Registration Rights Agreement, dated January 26, 2021, by and between the Company and the Sponsor. EX-10.3 7 tm214851d1ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 26, 2021, is made and entered into by and among CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), CA Healthcare Sponsor LLC, a Delaware limited liability company (the “Sponsor”; together with any person or entity wh |
|
| February 1, 2021 |
EX-4.1 4 tm214851d1ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of January 26, 2021, is by and between CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”). WHER |
|
| February 1, 2021 |
EX-10.4 8 tm214851d1ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of January 26, 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and between CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), and CA |
|
| February 1, 2021 |
CA Healthcare Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering EX-99.2 10 tm214851d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 CA Healthcare Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering January 26, 2021 BOSTON-(BUSINESS WIRE)-CA Healthcare Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Capital Market |
|
| February 1, 2021 |
Exhibit 1.1 UNDERWRITING AGREEMENT between CA Healthcare ACQUISITION CORP. and BTIG, LLC Dated January 26, 2021 CA HEALTHCARE ACQUISITION CORP. UNDERWRITING AGREEMENT New York, New York January 26, 2021 BTIG, LLC 65 East 55th Street New York, New York 10022 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, CA Healthcare Acquisition Corp., a Del |
|
| February 1, 2021 |
EX-10.1 5 tm214851d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 January 25, 2021 CA Healthcare Acquisition Corp. 99 Summer Street Suite 200 Boston, MA 02110 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between CA Healthcare Acquisition Corp. |
|
| February 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 1, 2021 (January 26, 2021) CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 001-39947 85-3469820 (State or other jurisdiction o |
|
| February 1, 2021 |
CA Healthcare Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering EX-99.3 11 tm214851d1ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 CA Healthcare Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering January 29, 2021 BOSTON-(BUSINESS WIRE)-CA Healthcare Acquisition Corp. (the “Company”) announced today the completion of its initial public offering of 11,500,000 units, including 1,500,000 units issued pursuant to the full exercise by the underwriter |
|
| January 27, 2021 |
$100,000,000 CA Healthcare Acquisition Corp. 10,000,000 Units TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(4) Registration No. 251969 PROSPECTUS $100,000,000 CA Healthcare Acquisition Corp. 10,000,000 Units CA Healthcare Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more business |
|
| January 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 CA Healthcare Acquisition Corp. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-3469820 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 99 Summer |
|
| January 20, 2021 |
Form of Compensation Committee Charter EX-99.2 16 tm213597d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 CHARTER OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS OF CA HEALTHCARE ACQUISITION CORP. I. PURPOSE OF THE COMMITTEE The purposes of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of CA Healthcare Acquisition Corp. (the “Company”) shall be to oversee the Company’s compensation and employee ben |
|
| January 20, 2021 |
Exhibit 10.1 January [], 2021 CA Healthcare Acquisition Corp. 99 Summer Street Suite 200 Boston, MA 02110 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), an |
|
| January 20, 2021 |
Form of Audit Committee Charter EX-99.1 15 tm213597d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 CA HEALTHCARE ACQUISITION CORP. AUDIT COMMITTEE CHARTER 1. STATUS The Audit Committee (the “Committee”) is a committee of the Board of Directors (the “Board”) of CA Healthcare Acquisition Corp. (the “Company”). 2. PURPOSE The Committee is appointed by the Board for the primary purposes of: ● Performing the Board’s oversight responsibilities |
|
| January 20, 2021 |
EX-10.7 13 tm213597d1ex10-7.htm EXHIBIT 10.7 Exhibit 10.7 FORM OF INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [ ], 2021, by and between CA Healthcare Acquisition Corp. (the “Company”), and the undersigned individual (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in |
|
| January 20, 2021 |
S-1/A 1 tm213597d1s1a.htm S-1/A As filed with the Securities and Exchange Commission on January 19, 2021 Registration No. 333-251969 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CA Healthcare Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware 6770 85-3469820 |
|
| January 20, 2021 |
EX-4.1 4 tm213597d1ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NUMBER UNITS U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 12510W 206 CA HEALTHCARE ACQUISITION CORP. UNITS CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-HALF OF ONE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one |
|
| January 20, 2021 |
Exhibit 4.3 [Form of Warrant Certificate] [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW CA HEALTHCARE ACQUISITION CORP. Incorporated Under the Laws of the State of Delaware CUSIP 12510W 115 Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is |
|
| January 20, 2021 |
EX-14 14 tm213597d1ex14.htm EXHIBIT 14 Exhibit 14 CODE OF ETHICS OF CA HEALTHCARE ACQUISITION CORP. 1. Introduction The Board of Directors (the “Board”) of CA Healthcare Acquisition Corp. has adopted this code of ethics (this “Code”), as amended from time to time by the Board and which is applicable to all of the Company’s directors, officers and employees to: ● promote honest and ethical conduct, |
|
| January 20, 2021 |
Form of Underwriting Agreement EX-1.1 2 tm213597d1ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 UNDERWRITING AGREEMENT between CA Healthcare ACQUISITION CORP. and BTIG, LLC Dated [●], 2021 CA HEALTHCARE ACQUISITION CORP. UNDERWRITING AGREEMENT New York, New York [●], 2021 BTIG, LLC 65 East 55th Street New York, New York 10022 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, CA Healthca |
|
| January 20, 2021 |
Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of [], 2021, is by and between CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”). WHEREAS, the Company is engaged in an initial public |
|
| January 20, 2021 |
Exhibit 10.6 FORM OF PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and between CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), and CA Healthcare Sponsor LLC, a Delaware limited l |
|
| January 20, 2021 |
Exhibit 10.4 FORM OF REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January [], 2021, is made and entered into by and among CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), CA Healthcare Sponsor LLC, a Delaware limited liability company (the “Sponsor”; together with any person or entity who hereafter becomes a party to this |
|
| January 20, 2021 |
Specimen Class A Common Stock Certificate Exhibit 4.2 NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 12510W 107 CA HEALTHCARE ACQUISITION CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE CLASS A COMMON STOCK OF CA HEALTHCARE ACQUISITION CORP. (THE “COMPANY”) transferable on the |
|
| January 20, 2021 |
Form of Amended and Restated Certificate of Incorporation Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CA HEALTHCARE ACQUISITION CORP. [], 2021 CA Healthcare Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “CA Healthcare Acquisition Corp.”. The certificate of incorporation of the Corporation was filed |
|
| January 20, 2021 |
Exhibit 10.3 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of January [], 2021, by and between CA Healthcare Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s registration statement on Form S-1, File No. 3 |
|
| January 8, 2021 |
Exhibit 99.3 Consent to Being Named as a Director Nominee In connection with the filing by CA Healthcare Acquisition Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of CA |
|
| January 8, 2021 |
EX-3.1 2 tm212115d1ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF CA HEALTHCARE ACQUISITION CORP. October 7, 2020 The undersigned, for the purposes of forming a corporation under the laws of the State of Delaware, does make, file, and record this Certificate of Incorporation (the “Certificate”), and does hereby certify as follows: ARTICLE I NAME The name of the corporation is CA |
|
| January 8, 2021 |
Exhibit 99.4 Consent to Being Named as a Director Nominee In connection with the filing by CA Healthcare Acquisition Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of CA |
|
| January 8, 2021 |
Power of Attorney (included on signature page)* As filed with the Securities and Exchange Commission on January 8, 2021 Registration No. |
|
| January 8, 2021 |
Exhibit 10.5 CA Healthcare Acquisition Corp. 99 Summer Street, Suite 200 Boston, Massachusetts 02110 October 28, 2020 CA Healthcare Sponsor LLC 99 Summer Street, Suite 200 Boston, Massachusetts 02110 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (this “Agreement”) is entered into on October 28, 2020 by and between, CA Healthcare Sponsor LLC, a Delaware limited liabilit |
|
| January 8, 2021 |
EX-3.3 3 tm212115d1ex3-3.htm EXHIBIT 3.3 Exhibit 3.3 BY LAWS OF CA HEALTHCARE ACQUISITION CORP. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting |
|
| January 8, 2021 |
Promissory Note, dated October 28, 2020, issued to CA Healthcare Sponsor LLC EX-10.2 4 tm212115d1ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY |
|
| January 8, 2021 |
Exhibit 99.5 Consent to Being Named as a Director Nominee In connection with the filing by CA Healthcare Acquisition Corp. of the Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of CA |
|
| November 17, 2020 |
CERTIFICATE OF INCORPORATION OF CA HEALTHCARE ACQUISITION CORP. October 7, 2020 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF CA HEALTHCARE ACQUISITION CORP. October 7, 2020 The undersigned, for the purposes of forming a corporation under the laws of the State of Delaware, does make, file, and record this Certificate of Incorporation (the ?Certificate?), and does hereby certify as follows: ARTICLE I NAME The name of the corporation is CA Healthcare Acquisition Corp. (the ?Corpo |
|
| November 17, 2020 |
DRS 1 filename1.htm This is a confidential draft submission to the U.S. Securities and Exchange Commission on November 17, 2020 and is not being filed under the Securities Act of 1933, as amended. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CA Healthcare Acquisition Corp. (Exact name |
|
| November 17, 2020 |
BY LAWS CA HEALTHCARE ACQUISITION CORP. (THE ?CORPORATION?) ARTICLE I Exhibit 3.3 BY LAWS OF CA HEALTHCARE ACQUISITION CORP. (THE ?CORPORATION?) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation?s registered agent in |
